A trauma formulation can fail a patient in two opposite directions: by reducing every symptom to PTSD, or by becoming so preoccupied with the differential that urgent safety and treatment are delayed.
Consider an illustrative case: a 31-year-old graphic designer, “Leah,” seen three months after an assault by a former partner. For this teaching example, assume the assault involved threatened serious injury, one way an exposure can meet DSM-5-TR Criterion A; if that element is absent, the clinician should not assume PTSD and should reassess the formulation. Since then, she has slept in brief fragments, wakes from vivid threat-themed dreams, avoids her former neighborhood, and startles violently when an elevator chime or a slammed door catches her off guard. She describes the city as looking “flat and unreal,” cannot reconstruct several minutes of the assault, and drinks wine most nights because it seems to be the only way she can fall asleep.
The immediate question is not simply, Does she have PTSD? It is: What is maintaining danger now, what requires parallel evaluation, and what treatment will help her learn safety without overwhelming her?
Start with safety before symptom counting
Leah says her former partner has tried to contact mutual friends and may know where she works. That changes the first task of the encounter. Meet privately, ask what contact is occurring now, whether there have been threats, stalking, access to weapons, escalating violence, or vulnerable children or dependents, and establish whether she can leave safely today.
A trauma-informed response is active but not coercive. Validate the disclosure, ask permission before exploring details, discuss safe ways to contact her, and offer connection to an intimate-partner-violence advocate or social worker. Explain confidentiality and its limits plainly, including any applicable local reporting duties and circumstances requiring action for imminent danger or child or other vulnerable-person safeguarding.
Safety planning restores choice. It should not become another person taking control away from the patient.
Suicide risk still needs direct reassessment even when the patient denies current intent. Severe insomnia, depression, alcohol use, isolation, ongoing threat, and dissociation can change risk quickly; asking about self-harm, hopelessness, access to lethal means, and protective relationships is part of good trauma care.
Name the syndrome—but do not stop there
On the assumed facts, Leah’s assault is a qualifying traumatic exposure. Her nightmares and cue-triggered distress suggest intrusion; her route changes and reminder avoidance support avoidance; hypervigilance and exaggerated startle fit arousal and reactivity; detachment, persistent fear, and trauma-related memory gaps may fit the cognition and mood domain. However, the memory gap should not be counted as trauma-related amnesia until head injury, intoxication or withdrawal, other substances, seizures, and other medical causes have been considered. At three months, if clinically significant impairment and the required exclusions are confirmed, PTSD is the leading formulation.
A high trauma screener supports urgency, not diagnostic closure. A structured interview such as the CAPS-5 can clarify symptom frequency, functional impact, the index trauma, and whether dissociative features are present.
The differential that matters in this room
| Possibility | Finding that supports it | Finding that helps distinguish it |
|---|---|---|
| PTSD, if full criteria are confirmed | Intrusions, avoidance, negative shifts in mood or cognition, and hyperarousal after a qualifying trauma | Symptoms organize around trauma reminders, persist for more than one month, cause impairment, and are not better explained by substances or a medical condition |
| Mild traumatic brain injury or post-concussive symptoms | Head impact, alteration or loss of consciousness, possible amnesia, sleep and concentration complaints | A normal CT excludes neither concussion nor persistent symptoms; ask about headache, dizziness, cognitive change, sensory sensitivity, and trajectory |
| Panic disorder | Recurrent panic episodes and fear of bodily sensations | PTSD attacks are often linked to reminders; panic disorder requires recurrent unexpected attacks plus persistent concern or behavior change centered on attacks themselves |
| Alcohol-related sleep or anxiety effects | Near-nightly alcohol use with early awakening, sweating, or morning anxiety | Alcohol may initially sedate but can fragment sleep and amplify rebound arousal; assess for alcohol use disorder and withdrawal risk |
Major depression commonly travels with PTSD and deserves its own assessment, especially when numbness is described. Ask whether low mood, anhedonia, guilt, appetite change, psychomotor changes, and suicidal thinking extend beyond trauma-linked avoidance and threat. Also assess for mania or hypomania before initiating an antidepressant.
Dissociation is a clinical finding, not a synonym for “numb”
The words numb and unreal deserve careful unpacking. Emotional numbing may occur within PTSD, while trauma-related inability to recall parts of the event may reflect dissociative amnesia. DSM-5-TR PTSD criteria specify that such a memory gap is not due to head injury, alcohol, or drugs. Before attributing it to dissociation, assess for head injury or loss of consciousness, intoxication or withdrawal, other substances, seizures, and other medical causes.
The dissociative specifier requires full PTSD plus persistent or recurrent depersonalization (“I felt outside my body” or “I was watching myself”) and or derealization (“the room felt dreamlike or unreal”), with reality testing intact. The dissociative symptoms must not be attributable to a substance or another medical condition. Asking for a concrete example is more useful than accepting a broad endorsement.
This distinction changes how treatment is delivered. Dissociation does not mean that trauma-focused therapy is contraindicated. It means the clinician should monitor whether the patient remains sufficiently present to learn: establish grounding skills, identify early signs of “checking out,” pace trauma work collaboratively, and return to orientation when arousal or detachment exceeds the patient’s workable range.
Fear conditioning helps explain the symptoms; extinction guides part of the treatment
A sudden sound is not dangerous in Leah’s clinic, yet her body reacts before deliberate reasoning catches up. In simplified terms, one explanatory model is that threat-learning circuits rapidly associate sensory cues with danger, while hippocampal systems help establish context and prefrontal systems support regulation and retrieval of safety learning.
Trauma-focused therapies do not delete the assault memory. In exposure-based treatment, the practical goal is new learning: the patient approaches trauma memories and safe reminders in a planned, tolerable way and learns that the cue can be experienced without the feared catastrophe occurring now. Cognitive Processing Therapy and EMDR use different procedures but likewise aim to change trauma-related meanings and responses. Context matters, which is why gains may feel robust in one setting and shaky in another.
This is a useful way to explain apparent “relapse.” A flare after hearing an alarm in a parking garage is not proof that therapy failed or that the patient has chosen avoidance. It may reflect renewal or reinstatement of conditioned fear in a new context. Treatment should anticipate this through varied practice, gradual generalization, and compassionate review rather than interpreting it as nonadherence.
For PTSD, individual trauma-focused psychotherapy should be offered when feasible and acceptable and is prioritized over medication when both are available and feasible. Cognitive Processing Therapy, Prolonged Exposure, and EMDR have the strongest support. Choice matters: a patient who understands the rationale, expected discomfort, alternatives, and plan for managing dissociation is better positioned to engage.
A common board-style trap is to turn an elegant neurobiologic hypothesis into routine practice. NMDA-related enhancement of extinction learning has been studied, but D-cycloserine augmentation is not standard PTSD care; the VA/DoD guideline suggests against combining it with exposure therapy outside a research setting.
Repair the sleep-and-alcohol loop without substituting one sedative for another
Alcohol can shorten sleep onset while fragmenting sleep and promoting earlier waking. For a patient with nightmares, this creates a powerful but misleading loop: drink to fall asleep, awaken distressed, then experience worse baseline sleep and anxiety over time.
Do not respond with a reflexive instruction to stop drinking immediately without assessing dependence. Clarify quantity, duration, morning use, prior withdrawal symptoms, seizures, blackouts, other substances, and the timing of the last drink. If withdrawal risk is meaningful, arrange an appropriate medically supervised plan rather than leaving the patient to manage it alone.
Behavioral insomnia treatment, a regular wake time, reduction of alcohol, and nightmare-focused treatment can be considered alongside PTSD care. Medication can be useful, but it should support—not replace—safety planning, alcohol treatment, and trauma-focused psychotherapy.
For core PTSD symptoms when medication is preferred, needed for comorbid depression, or psychotherapy is not available, sertraline, paroxetine, and venlafaxine have the strongest guideline support. Choose with attention to prior response, adverse-effect burden, reproductive considerations, comorbid conditions, and patient preference.
Prazosin may be considered specifically for trauma-related nightmares through shared decision-making, not as a treatment for all PTSD symptoms. Discuss the mixed evidence, monitor blood pressure and orthostatic symptoms, and reassess whether it is producing a meaningful benefit. Benzodiazepines are not recommended for PTSD; in Leah’s case, concurrent alcohol use makes sedation, dependence, and overdose-related risks especially concerning.
Common traps in this presentation
- Calling every surge of dyspnea “panic disorder.” First determine whether attacks are unexpected or predictably tied to trauma cues.
- Treating a normal CT as a normal brain. Structural imaging does not rule out concussion; persistent cognitive, vestibular, or headache symptoms may merit targeted follow-up.
- Equating memory gaps with malingering or psychosis. Trauma-related amnesia, dissociation, intoxication effects, and brain injury each require respectful assessment.
- Forcing detailed disclosure to prove the diagnosis. The goal is adequate clinical information and present safety, not a forensic reconstruction.
- Prescribing sedation as the primary answer to nightmares. It may obscure alcohol-related harm and bypass the mechanisms sustaining PTSD.
- Withholding trauma-focused care solely because dissociation is present. Instead, modify pacing and monitor dissociative symptoms.
Practical takeaways
- In trauma care, assess current danger and safe contact methods before launching into diagnostic detail.
- PTSD is likely when symptom clusters, duration, impairment, and required exclusions fit; screening scores alone do not settle the diagnosis.
- Derealization and depersonalization—not numbness alone—support the dissociative subtype only when full PTSD is present and substance or medical causes have been excluded.
- Cue-linked panic often reflects conditioned fear within PTSD; recurrent unexpected attacks raise the possibility of co-occurring panic disorder.
- A normal CT does not exclude mild TBI, and nightly alcohol can independently perpetuate insomnia and hyperarousal.
- Trauma-focused psychotherapy does not erase memory. Exposure-based work builds new safety learning; pace it so the patient can remain engaged rather than dissociating.
- Treat nightmares and medication decisions with shared decision-making, while avoiding benzodiazepines and addressing alcohol use directly.
